title: Psychopharmacologic treatment of obesity and eating disorders in children and adolescents.
abstract: This review discusses the evidence base for medications that are currently used for obesity and eating disorders, including their Food and Drug Administration approval status by disorder and age group, contraindications, and major adverse effects. Investigational agents currently being considered, issues related to psychiatric and medical comorbidity, limitations of pharmacologic strategies, and recommendations for treatment are also addressed.
authors.affiliation: Department of Pediatrics, Center for Eating and Weight Disorders, College of Medicine, University of South Florida, Tampa, FL 33613, USA. ppowers@health.usf.edu
authors.forename: Pauline S
authors.initials: PS
authors.lastname: Powers
authors.forename: Nancy L
authors.initials: NL
authors.lastname: Cloak
mesh_terms: D000293:Adolescent; D000928:Antidepressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D000075202:Contraindications; D019317:Evidence-Based Medicine; D001068:Feeding and Eating Disorders / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D055118:Medication Adherence; D009765:Obesity / Q000150:complications / Q000188:drug therapy*; D011613:Psychotherapy
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents